Literature DB >> 22931704

The haplotype of the TGFβ1 gene associated with cerebral infarction in Chinese.

Hong-miao Tao1, Guo-zhong Chen, Gan-ping Cheng, Xiao-yun Shan.   

Abstract

BACKGROUND: Transforming growth factor beta1 (TGFβ1) is a multifunctional cytokine involved in inflammation and pathogenesis of atherosclerosis. The aim of the present study was to investigate the relationship between human TGFβ1 gene +869T>C (rs1800470), -509C>T (rs1800469) single nucleotide polymorphisms (SNPs) and haplotypes and cerebral infarction (CI) in a Chinese population.
METHODS: The genetic association study was performed in 450 Chinese patients (306 male and 144 female) with CI and 450 control subjects (326 male and 124 female). TGFβ1 gene +869T>C and -509C>T polymorphisms were identified with amplification refractory mutation system polymerase chain reaction and DNA sequencing method.
RESULTS: The individual SNPs analysis showed the +869T and -509C in an additive model (+869T vs +869C; -509 C vs T), +869TT genotype in a recessive model (TT vs TC+CC) and 509CC genotype in a dominant model (CC+ CT vs TT) were identified to be related to CI (P<0.05). +869T>C and -509C>T SNPs were in strong linkage disequilibrium (d'=0.87, R2=0.75). Haplotype analysis showed that +869C/-509T haplotype was associated with a significant decreased risk of CI (OR= 0.86, 95%CI, 0.70-0.92; P=0.007). Furthermore,+869T/-509C haplotype was associated with a significant increased risk of CI (OR=1.31, 95%CI, 1.10-2.03; P=0.019).
CONCLUSIONS: The results of this study indicate that polymorphisms and the haplotypes in the TGFβ1 gene might be genetic markers for CI in the Chinese population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22931704     DOI: 10.1017/s0317167100015365

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  7 in total

1.  Association of transforming growth factor-β1 gene C509T, G800A and T869C polymorphisms with intracerebral hemorrhage in North Indian Population: a case-control study.

Authors:  Pradeep Kumar; Amit Kumar; Shubham Misra; Ram Sagar; Mohammad Farooq; Renu Kumari; Subiah Vivekanandhan; Achal Kumar Srivastava; Kameshwar Prasad
Journal:  Neurol Sci       Date:  2015-11-30       Impact factor: 3.307

2.  Cyclooxygenase-2 genetic polymorphism and stroke subtypes in Chinese.

Authors:  Guo-zhong Chen; Xiao-yun Shan; Gan-ping Cheng; Hong-miao Tao
Journal:  J Mol Neurosci       Date:  2013-08-02       Impact factor: 3.444

3.  Cyclooxygenase 2 genetic polymorphism may increase the risk of developing leukoaraiosis in Chinese.

Authors:  Xiao-yun Shan; Guo-zhong Chen; Gan-ping Cheng; Hong-miao Tao
Journal:  J Mol Neurosci       Date:  2013-07-13       Impact factor: 3.444

4.  The Relationship between VEGFA and TGFB1 Polymorphisms and Target Lesion Revascularization after Elective Percutaneous Coronary Intervention.

Authors:  Tadeusz Osadnik; Andrzej Lekston; Kamil Bujak; Joanna Katarzyna Strzelczyk; Lech Poloński; Mariusz Gąsior
Journal:  Dis Markers       Date:  2017-07-24       Impact factor: 3.434

5.  Transforming growth factor-β1 (C509T, G800A, and T869C) gene polymorphisms and risk of ischemic stroke in North Indian population: A hospital-based case-control study.

Authors:  Pradeep Kumar; Shubham Misra; Amit Kumar; Mohammad Faruq; Sunil Shakya; Gyan Vardhan; Subiah Vivekanandhan; Achal Kumar Srivastava; Kameshwar Prasad
Journal:  Ann Indian Acad Neurol       Date:  2017 Jan-Mar       Impact factor: 1.383

6.  Genome-Wide DNA Methylation Pattern in Whole Blood Associated With Primary Intracerebral Hemorrhage.

Authors:  Yupeng Zhang; Hongyu Long; Sai Wang; Wenbiao Xiao; Meishan Xiong; Jianyi Liu; Lei Chen; Ruijuan Chen; Xueli Wei; Yi Shu; Yi Zeng; Le Zhang
Journal:  Front Immunol       Date:  2021-08-13       Impact factor: 7.561

7.  Association of TGF-β1, IL-4, and IL-10 Polymorphisms With Chronic Kidney Disease Susceptibility: A Meta-Analysis.

Authors:  Meifang Mai; Yinlian Jiang; Xiaoman Wu; Gengrong Liu; Yaoli Zhu; Weiping Zhu
Journal:  Front Genet       Date:  2020-02-27       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.